Sorry!! The article you are trying to read is not available now.
Pfizer Inc. (NY: PFE)
30.82 USD  -0.18 (-0.58%)
Streaming Delayed Price  /  Updated: 1:52 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(PFE) Community Analysis from
April 23, 2014
(Jutia Group, 4/22/14)
[Business Wire] - Pfizer Inc. announced today top-line results...(read more)
(Gold Stocks Today, 1/17/14)
Ernie Tremblay writes: Traditional pharmaceutical blockbusters like Pfizer's Lipitor treat millions of patients at relatively low cost. It's a high-volume business model that has kept the pharmaceutical industry afloat for a long, long time. ...
(Stock Blog Hub, 9/17/13)
Pfizer Inc. (PFE) recently faced a pipeline setback with the company discontinuing a late-stage study being conducted with its oncology candidate, inotuzumab ozogamicin. The randomized,...(read more)
Pfizer (PFE) Company Overview

Pfizer Inc. (NYSE:PFE) is the largest pharmaceutical company in the world. It owns the best selling medicine in the world, cholesterol-lowering drug Lipitor and has 14 other blockbuster drugs (annual sales >$1B).[1] In FY 2010, Pfizer generated revenues of $67.8 billion and net income of $8.26B.[2]

As the largest player in the pharmaceutical market, Pfizer has greater power in marketing and forming alliances.[3] The company also consistently posts the highest dividends in the industry.[3] However, Pfizer faces challenges common to all players in the pharmaceutical industry, including issues surrounding patent expiration and FDA regulation.

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here